List of Veracast ConferenCenter Customers
Dublin, 43017-2372, OH,
United States
Since 2010, our global team of researchers has been studying Veracast ConferenCenter customers around the world, aggregating massive amounts of data points that form the basis of our forecast assumptions and perhaps the rise and fall of certain vendors and their products on a quarterly basis.
Each quarter our research team identifies companies that have purchased Veracast ConferenCenter for Event Management from public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources, including the customer size, industry, location, implementation status, partner involvement, LOB Key Stakeholders and related IT decision-makers contact details.
Companies using Veracast ConferenCenter for Event Management include: Boston Scientific Corp, a United States based Life Sciences organisation with 53000 employees and revenues of $16.74 billion, Incyte Corporation, a United States based Life Sciences organisation with 2324 employees and revenues of $3.39 billion, Sarepta Therapeutics, a United States based Life Sciences organisation with 1314 employees and revenues of $1.24 billion, Emergent BioSolutions, a United States based Life Sciences organisation with 1600 employees and revenues of $1.05 billion, Alnylam Pharmaceuticals, Inc., a United States based Life Sciences organisation with 2002 employees and revenues of $1.04 billion and many others.
Contact us if you need a completed and verified list of companies using Veracast ConferenCenter, including the breakdown by industry (21 Verticals), Geography (Region, Country, State, City), Company Size (Revenue, Employees, Asset) and related IT Decision Makers, Key Stakeholders, business and technology executives responsible for the software purchases.
The Veracast ConferenCenter customer wins are being incorporated in our Enterprise Applications Buyer Insight and Technographics Customer Database which has over 100 data fields that detail company usage of software systems and their digital transformation initiatives. Apps Run The World wants to become your No. 1 technographic data source!
Apply Filters For Customers
| Logo | Customer | Industry | Empl. | Revenue | Country | Vendor | Application | Category | When | SI | Insight |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
ACADIA Pharmaceuticals Inc. | Life Sciences | 510 | $484M | United States | Veracast Communications | Veracast ConferenCenter | Event Management | 2022 | n/a |
In 2022, ACADIA Pharmaceuticals Inc. implemented Veracast ConferenCenter to publish and stream event webcasts embedded on its website. Veracast ConferenCenter is deployed as an Event Management application supporting corporate communications and investor webcast delivery for ACADIA Pharmaceuticals Inc.
The implementation emphasizes web-based webcast hosting and on-demand playback delivered through ACADIA's public site, using Veracast ConferenCenter modules aligned with live streaming, registration workflows, and archive playback. Operational scope centers on external communications and investor relations, with configuration and governance structured around embed delivery, content scheduling, access controls, and communications team administration of event scheduling and public access policy.
|
|
|
Adaptive Biotechnologies | Life Sciences | 790 | $185M | United States | Veracast Communications | Veracast ConferenCenter | Event Management | 2022 | n/a |
In 2022, Adaptive Biotechnologies deployed Veracast ConferenCenter on its public website to publish and manage corporate event webcasts. Veracast ConferenCenter is operating as an Event Management application, embedded into the corporate site to deliver live streaming sessions and host on-demand recordings for externally facing events.
The implementation emphasizes standard Event Management functional areas including session scheduling, live stream publishing, on-demand archive hosting, and content provisioning workflows. Operational governance centers on role-based content publishing and scheduling processes to support corporate communications and external event orchestration, consistent with typical event management deployment patterns.
|
|
|
Alector, Inc. | Life Sciences | 237 | $227M | United States | Veracast Communications | Veracast ConferenCenter | Event Management | 2019 | n/a |
In 2019, Alector, Inc. deployed Veracast ConferenCenter to publish and stream corporate conference webcasts on its public website. This implementation uses Veracast ConferenCenter within the Event Management category to host scheduled live webcasts and on-demand playback pages linked from the company site, surfacing event content to external audiences.
The deployment is implemented as an embedded webcast and conference page solution on Alector’s website and is operated through centralized communications workflows. Functional capabilities in use align with Event Management patterns, including event scheduling, live streaming delivery and archived playback for investor and scientific presentations, and the solution is positioned to support marketing and corporate communications event operations.
|
|
|
Alnylam Pharmaceuticals, Inc. | Life Sciences | 2002 | $1.0B | United States | Veracast Communications | Veracast ConferenCenter | Event Management | 2022 | n/a |
In 2022, Alnylam Pharmaceuticals, Inc. deployed Veracast ConferenCenter to host and publish live and on-demand webcast content directly on its website, using Veracast ConferenCenter as the primary Event Management vehicle for external event delivery. The implementation is surfaced through the corporate web channel, positioning the application as the public-facing event and webcast layer for conference presentations and investor-facing sessions.
The deployment leverages category-aligned functional capabilities typical of Event Management platforms, including attendee registration and access control, live webcast streaming, session scheduling, and on-demand archive delivery. Veracast ConferenCenter is used to orchestrate presentation workflows, manage session assets, and provide event-level analytics and reporting for published webcasts.
Operational ownership is aligned with external communications and investor relations use cases, with content published via the corporate website and web-based access points. Governance and content publishing workflows are configured to support scheduled conference broadcasts and on-demand replay, while integrations with internal systems were not specified in public sources.
|
|
|
Apellis Pharmaceuticals | Life Sciences | 780 | $199M | United States | Veracast Communications | Veracast ConferenCenter | Event Management | 2021 | n/a |
In 2021 Apellis Pharmaceuticals implemented Veracast ConferenCenter on its website to manage and present scheduled and on demand webcasts. Veracast ConferenCenter is deployed as the company facing event publication layer and is surfaced directly through Apellis web properties.
The deployment aligns with Event Management capabilities such as webcast hosting, embedded media player delivery, event scheduling and registration workflows, and on demand archive publishing. Configuration emphasis is on web conferencing and external content delivery, centralizing event assets and playback under a single content management and distribution framework. Veracast ConferenCenter is the explicit application used to publish and host those external events.
No third party system integrations are specified in source materials, the implementation is described as web hosted and client embedded rather than as part of a broader integration program. Operational scope centers on external events and corporate communications, supporting public webcasts and recorded presentations accessible from the Apellis website. This positions Veracast ConferenCenter as the primary outward facing Event Management tool for webcasting and public event distribution at Apellis.
Reported governance details focus on site level publishing controls and scheduling workflows, with publisher access and content management implied by the application usage. The available information describes the technical presence and functional coverage of Veracast ConferenCenter rather than operational metrics or cost outcomes.
|
|
|
|
Life Sciences | 53000 | $16.7B | United States | Veracast Communications | Veracast ConferenCenter | Event Management | 2022 | n/a |
|
|
|
|
Life Sciences | 1600 | $1.0B | United States | Veracast Communications | Veracast ConferenCenter | Event Management | 2022 | n/a |
|
|
|
|
Life Sciences | 954 | $232M | United States | Veracast Communications | Veracast ConferenCenter | Event Management | 2022 | n/a |
|
|
|
|
Life Sciences | 457 | $194M | United States | Veracast Communications | Veracast ConferenCenter | Event Management | 2022 | n/a |
|
|
|
|
Life Sciences | 1161 | $527M | United Kingdom | Veracast Communications | Veracast ConferenCenter | Event Management | 2022 | n/a |
|
Buyer Intent: Companies Evaluating Veracast ConferenCenter
Discover Software Buyers actively Evaluating Enterprise Applications
| Logo | Company | Industry | Employees | Revenue | Country | Evaluated | ||
|---|---|---|---|---|---|---|---|---|
| No data found | ||||||||